Reposted by Cambridge Baker Systems Genomics Initiative
Briefly, in this study we use plasma proteomics to construct new and substantially improved risk models for recurrent CVD, which themselves comprise new biomarkers that we can further compress into 5 commercially available protein ELISAs. Check out the paper for more! www.medrxiv.org/content/10.6...
medrxiv.org